Search Results (92)

Paper-based electrochemical biosensors have emerged as a revolutionary technology in healthcare diagnostics due to their affordability, portability, ease of use, and environmental sustainability. These biosensors utilize paper as the primary material, capitalizing on its unique properties such as high porosity, flexibility, and capillary action, which make it an ideal candidate for low-cost, functional, and reliable diagnostic devices. The simplicity and cost-effectiveness of paper-based biosensors make them especially suitable for point-of-care (POC) applications, particularly in resource-limited settings where traditional diagnostic tools may be inaccessible. Their lightweight nature and ease of operation allow non-specialized users to perform diagnostic tests without the need for complex laboratory equipment, making them suitable for emergency, field, and remote applications. Technological advancements in paper-based biosensors have significantly enhanced their capabilities. Integration with microfluidic systems has improved fluid handling and reagent storage, resulting in enhanced sensor performance, including greater sensitivity and specificity for target biomarkers. The use of nanomaterials in electrode fabrication, such as reduced graphene oxide and gold nanoparticles, has further elevated their sensitivity, allowing for the precise detection of low-concentration biomarkers. Moreover, the development of multiplexed sensor arrays has enabled the simultaneous detection of multiple biomarkers from a single sample, facilitating comprehensive and rapid diagnostics in clinical settings. These biosensors have found applications in diagnosing a wide range of diseases, including infectious diseases, cancer, and metabolic disorders. They are also effective in genetic analysis and metabolic monitoring, such as tracking glucose, lactate, and uric acid levels, which are crucial for managing chronic conditions like diabetes and kidney diseases. In this review, the latest advancements in paper-based electrochemical biosensors are explored, with a focus on their applications, technological innovations, challenges, and future directions. Full article

Thanks to their low-cost, portability, and sustainability, microfluidic thread-based analytical devices (μTADs) are emerging as an attractive analytical platform for wearable biosensing. While several μTADs, mainly based on colorimetric and electrochemical detection methods, have been developed, achieving the needed sensitivity and accuracy for these biosensors continues to present a significant challenge. Prompted by this need we investigated for the first time the implementation of chemiluminescence (CL) as a detection technique for μTADs. Exploiting the lactate oxidase-catalyzed reaction coupled with the enhanced luminol/H₂O₂/horseradish peroxidase CL system, we developed a cotton-thread-based chemiluminescent device enabling the detection of lactate with a limit of detection of 0.25 mM in a 2 µL volume of artificial sweat at pH 6.5 within 3 min. The use of recycled grape skin as support made the device sustainable, while the smartphone detection allowed a simple and quantitative readout for the end-user. Using a smartphone as a detector, the analytical performance was evaluated in different conditions and in the presence of potential interferents, showing suitability for monitoring lactate levels in physiological conditions, such as for monitoring anaerobic thresholds in endurance training. Full article

We are reporting the development of a high-performance, non-enzymatic electrochemical biosensor for selective lactate detection, integrating laser-induced graphene (LIG), gold nanoparticles (AuNPs), and a molecularly imprinted polymer (MIP) synthesized from poly(3,4-ethylenedioxythiophene) (PEDOT). The LIG electrode offers a highly porous, conductive scaffold, while electrodeposited AuNPs enhance catalytic activity and signal amplification. The PEDOT-based MIP layer, electropolymerized via cyclic voltammetry, imparts molecular specificity by creating lactate-specific binding sites. Cyclic voltammetry confirmed successful molecular imprinting and enhanced interfacial electron transfer. The resulting LIG/AuNPs/MIP biosensor demonstrated a wide linear detection range from 0.1 µM to 2500 µM, with a sensitivity of 22.42 µA/log(µM) and a low limit of detection (0.035 µM). The sensor showed excellent selectivity against common electroactive interferents such as glucose and uric acid, long-term stability, and accurate recovery in artificial saliva (>95.7%), indicating strong potential for practical application. This enzyme-free platform offers a robust and scalable strategy for continuous lactate monitoring, particularly suited for wearable devices in sports performance monitoring and critical care diagnostics. Full article

A biosensor for the determination of glucose, lactate, ethanol and starch in beverages has been developed using enzymes immobilized by a redox-active gel on a screen-printed electrode. A significant improvement proposed for multichannel biosensors, overcoming stability and sensitivity issues by covalently binding phenazine mediators to a biocompatible protein hydrogel, enhancing the packaging of the enzyme. Glucose oxidase (GOx), alcohol oxidase (AOx) and lactate oxidase (LOx) were used as biological materials, as well as a mixture of GOx with γ-amylase (Am). Redox gels were synthesized from bovine serum albumin (BSA) and phenazine derivatives. It was shown that a neutral red-based redox gel combined with single-walled carbon nanotubes is more promising than other substrates for enzyme immobilization. The lower limit of quantification for glucose, ethanol, lactate and starch using these systems is 0.035 mM, 2.3 mM, 15 mM and 2 mg/L, respectively. Biosensors were used to analyze the content of these substances in alcoholic, kvass and fermentation mass. Statistical analysis of the results showed that the values of glucose, ethanol, lactic acid and starch determined using biosensors and obtained by reference methods differ insignificantly. A set of biosensors developed on the basis of specifically selected enzymes is effective for controlling biotechnological processes and can be used as an alternative to classical analytical methods. Full article

Amperometric biosensors (ABSs) and enzymatic biofuel cells (BFCs) share several fundamental principles in their functionality, despite serving different primary purposes. Both devices rely on biorecognition, redox reactions, electron transfer (ET), and advanced electrode materials, including innovative nanomaterials (NMs). ABSs and BFCs, utilizing microbial oxidoreductases in combination with electroactive NMs, are both efficient and cost-effective. In the current study, several laboratory prototypes of BFCs have been developed with bioanodes based on yeast flavocytochrome b₂ (Fcb₂) and alcohol oxidase (AO), and a cathode based on fungal laccase. For the first time, BFCs have been developed featuring anodes based on Fcb₂ co-immobilized with redox NMs on a glassy carbon electrode (GCE), and cathode-utilizing laccase combined with gold–cerium–platinum nanoparticles (nAuCePt). The most effective lactate BFC, which contains gold–hexacyanoferrate (AuHCF), exhibited a specific power density of 1.8 µW/cm². A series of BFCs were developed with an AO-containing anode and a laccase/nAuCePt/GCE cathode. The optimal configuration featured a bioanode architecture of AO/nCoPtCu/GCE, achieving a specific power density of 3.2 µW/cm². The constructed BFCs were tested using lactate-containing food product samples as fuels. Full article

Enzymatic biofuel cells (EBFCs) have emerged as a transformative solution in the quest for sustainable energy, offering a biocatalyst-driven alternative for powering wearable and implantable self-powered biosensors. These systems harness renewable enzyme activity under mild conditions, positioning them as ideal candidates for next-generation biosensing applications. Despite their promise, their practical deployment is limited by challenges such as low power density, restricted operational lifespan, and miniaturization complexities. This review provides an in-depth exploration of the evolving landscape of EBFC technology, beginning with fundamental principles and the latest developments in electron transfer mechanisms. A critical assessment of enzyme immobilization techniques, including physical adsorption, covalent binding, entrapment, and cross-linking, underscores the importance of optimizing enzyme stability and catalytic activity for enhanced bioelectrode performance. Additionally, we examine advanced bioelectrode materials, focusing on the role of nanostructures such as carbon-based nanomaterials, noble metals, conducting polymers, and metal–organic frameworks in improving electron transfer and boosting biosensor efficiency. Also, this review includes case studies of EBFCs in wearable self-powered biosensors, with particular attention to the real-time monitoring of neurotransmitters, glucose, lactate, and ethanol through sweat analysis, as well as their integration into implantable devices for continuous healthcare monitoring. Moreover, a dedicated discussion on challenges and trends highlights key limitations, including durability, power management, and scalability, while presenting innovative approaches to address these barriers. By addressing both technical and biological constraints, EBFCs hold the potential to revolutionize biomedical diagnostics and environmental monitoring, paving the way for highly efficient, autonomous biosensing platforms. Full article

Artificial enzymes or nanozymes (NZs) are gaining significant attention in biotechnology due to their stability and cost-effectiveness. NZs can offer several advantages over natural enzymes, such as enhanced stability under harsh conditions, longer shelf life, and reduced production costs. The booming interest in NZs is likely to continue as their potential applications expand. In our previous studies, we reported the “green” synthesis of copper hexacyanoferrate (gCuHCF) using the oxidoreductase flavocytochrome b₂ (Fcb₂). Organic–inorganic micro-nanoparticles were characterized in detail, including their structure, composition, catalytic activity, and electron-mediator properties. An SEM analysis revealed that gCuHCF possesses a flower-like structure well-suited for concentrating and stabilizing Fcb₂. As an effective peroxidase (PO) mimic, gCuHCF has been successfully employed for H₂O₂ detection in amperometric sensors and in several oxidase-based biosensors. In the current study, we demonstrated the uniqueness of gCuHCF that lies in its multifunctionality, serving as a PO mimic, a chemosensor for ammonium ions, a biosensor for L-lactate, and exhibiting perovskite-like properties. This exceptional ability of gCuHCF to enhance fluorescence under blue light irradiation is being reported for the first time. Using gCuHCF as a PO-like NZ, novel oxidase-based sensors were developed, including an optical biosensor for L-arginine analysis and electrochemical biosensors for methanol and glycerol determination. Thus, gCuHCF, synthesized via Fcb₂, presents a promising platform for the development of amperometric and optical biosensors, bioreactors, biofuel cells, solar cells, and other advanced devices. The innovative approach of utilizing biocatalysts for nanoparticle synthesis highlights a groundbreaking direction in materials science and biotechnology. Full article

Lactate is a key metabolite in cellular respiration, and elevated levels usually indicate tissue hypoxia or metabolic dysregulation. The real-time detection of lactate levels is particularly important in situations such as exercise, shock, severe trauma, and tissue injury. Conventional lactate assays are insufficient to address today’s complex and variable testing environments, and thus, there is an urgent need for highly sensitive biosensors. This review article provides an overview of the concept and composition of electrochemical lactate biosensors, as well as their recent advances. Comparisons of popular studies on enzymatic and non-enzymatic lactate sensors, the surface-related materials used for modifications to electrochemical lactate biosensors, and the detection methods commonly used for sensors are discussed separately. In addition, advances in implantable and non-implantable miniaturized lactate sensors are discussed, emphasizing their application for continuous real-time monitoring. Despite their potential, challenges such as non-specific binding, biomaterial interference, and biorecognition element stability issues remain during practical applications. Future research should aim to improve sensor design, biocompatibility, and integration with advanced signal processing techniques. With continued innovation, lactate sensors are expected to revolutionize personalized medicine, helping clinicians to increase treatment efficiency and improve the experience of their use. Full article

Prussian Blue (PB) is commonly incorporated into screen-printed enzymatic devices since it enables the determination of the enzymatically produced hydrogen peroxide at low potentials. Inkjet printing is gaining popularity in the development of electrochemical sensors as a substitute for screen printing. This work presents a fully inkjet-printed graphene–Prussian Blue platform, which can be paired with oxidase enzymes to prepare a biosensor of choice. The graphene electrode was inkjet-printed on a flexible polyimide substrate and then thermally and photonically treated with intense pulsed light, followed by inkjet printing of a PB nanoparticle suspension. The optimization of post-printing treatment and electrode deposition conditions was performed to yield a platform with minimal sheet resistance and peak potential differences. A thorough study of PB deposition was conducted: the fully inkjet-printed system was compared against sensors with PB deposited chemically or by drop casting the PB suspension on different kinds of carbon electrodes (glassy carbon, commercial screen-printed, and in-house inkjet-printed electrodes). For hydrogen peroxide detection, the fully inkjet-printed platform exhibits excellent sensitivity, a wider linear range, better linearity, and greater stability towards higher concentrations of peroxide than the other tested electrodes. Finally, lactate oxidase was immobilized in a chitosan matrix, and the prepared biosensor exhibited analytical performance comparable to other lactate sensors found in the literature in a wide, physiologically relevant linear range for measuring lactate concentration in sweat. The development of mediator-modified electrodes with a single fabrication technology, as demonstrated here, paves the way for the scalable production of low-cost, wearable, and flexible biosensors. Full article

Recent studies have shown that lactate is a molecule that plays an indispensable role in various physiological cellular processes, such as energy metabolism and signal transductions related to immune and inflammatory processes. For these reasons, interest in its detection using biosensors for non-invasive analyses of sweat during sports activity and in clinical reasons assessments has increased. In this minireview, an in-depth study was carried out on biosensors that exploited using electrochemical methods and innovative nanomaterials for lactate detection in sweat. This detection of lactate by biosensors in the sweat method seems to be feasible and highly desirable. From this commentary analysis, we can conclude that the correlation between lactate concentrations in sweat and blood is not yet clear, and studies are needed to clarify some key issues essential for the future application of this technology. Full article

Hypoxia, characterized by inadequate tissue oxygenation, may result in tissue damage and organ failure if not addressed. Current detection approaches frequently prove insufficient, depending on symptoms and rudimentary metrics such as tissue oxygenation, which fail to comprehensively identify the onset of hypoxia. The European Pressure Ulcer Advisory Panel (EPUAP) has recognized sweat lactate as a possible marker for the early identification of decubitus ulcers, nevertheless, neither sweat lactate nor oxygenation independently provides an appropriate diagnosis of hypoxia. We have fabricated a wearable device that non-invasively and concurrently monitors sweat lactate and tissue oxygenation to fill this gap. The apparatus comprises three essential components: (i) a hydrogel-based colorimetric lactate biosensor, (ii) a near-infrared (NIR) sensor for assessing tissue oxygenation, and (iii) an integrated form factor for enhanced wearability. The lactate sensor alters its hue upon interaction with lactate in sweat, whereas the NIR sensor monitors tissue oxygenation levels in real-time. The device underwent testing on phantom exhibiting tissue-mimicking characteristics and on human sweat post aerobic and anaerobic activities. Moreover, the device was demonstrated to be capable of real-time “on-body” simultaneous monitoring of sweat lactate spikes and tissue oxygenation (StO₂) drops, which showed strong correlation during a hypoxia protocol. This innovative technology has a wide range of potential applications, such as post-operative care, sepsis detection, and athletic performance monitoring, and may provide economical healthcare solutions in resource-limited regions. Full article

Wearable technology has advanced significantly, offering real-time monitoring of athletes’ physiological parameters and optimizing training and recovery strategies. Recent developments focus on biosensor devices capable of monitoring biochemical parameters in addition to physiological ones. These devices employ noninvasive methods such as sweat analysis, which reveals critical biomarkers like glucose, lactate, electrolytes, pH, and cortisol. These biomarkers provide valuable insights into an athlete’s energy use, hydration status, muscle function, and stress levels. Current technologies utilize both electrochemical and colorimetric methods for sweat analysis, with electrochemical methods providing higher precision despite potential signal interference. Wearable devices such as epidermal patches, temporary tattoos, and fabric-based sensors are preferred for their flexibility and unobtrusive nature compared to more rigid conventional wearables. Such devices leverage advanced materials and transmit real-time data to computers, tablets, or smartphones. These data would aid coaches and sports medical personnel in monitoring athletes’ health, optimizing diets, and developing training plans to enhance performance and reduce injuries. Full article

We report the development of amperometric biosensors (ABSs) employing flavocytochrome b₂ (Fcb₂) coupled with nanoparticles (NPs) of noble metals on graphite electrode (GE) surfaces. Each NPs/GE configuration was evaluated for its ability to decompose hydrogen peroxide (H₂O₂), mimicking peroxidase (PO) activity. The most effective nanoPO (nPO) was selected for developing ABSs targeting L-lactate. Consequently, several Fcb₂/nPO-based ABSs with enhanced sensitivity to L-lactate were developed, demonstrating mediated ET between Fcb₂ and the GE surface. The positive effect of noble metal NPs on Fcb₂-based sensor sensitivity may be explained by the synergy between their dual roles as both PO mimetics and electron transfer mediators. Furthermore, our findings provide preliminary data that may prompt a re-evaluation of the mechanism of L-lactate oxidation in Fcb₂-mediated catalysis. Previously, it was believed that L-lactate oxidation via Fcb₂ catalysis did not produce H₂O₂, unlike catalysis via L-lactate oxidase. Our initial research revealed that the inclusion of nPO in Fcb₂-based ABSs significantly increased their sensitivity. Employing other PO mimetics in ABSs for L-lactate yielded similar results, reinforcing our hypothesis that trace amounts of H₂O₂ may be generated as a transient intermediate in this reaction. The presence of nPO enhances the L-lactate oxidation rate through H₂O₂ utilization, leading to signal amplification and heightened bioelectrode sensitivity. The proposed ABSs have been successfully tested on blood serum and fermented food samples, showing their promise for L-lactate monitoring in medicine and the food industry. Full article

With improvements in medical environments and the widespread use of smartphones, interest in wearable biosensors for continuous body monitoring is growing. We developed a wearable multiplexed bio-sensing system that non-invasively monitors body fluids and integrates with a smartphone application. The system includes sensors, readout circuits, and a microcontroller unit (MCU) for signal processing and wireless communication. Potentiometric and amperometric measurement methods were used, with calibration capabilities added to ensure accurate readings of analyte concentrations and temperature. Laser-induced graphene (LIG)-based sensors for glucose, lactate, Na⁺, K⁺, and temperature were developed for fast, cost-effective production. The LIG electrode’s 3D porous structure provided an active surface area 16 times larger than its apparent area, resulting in enhanced sensor performance. The glucose and lactate sensors exhibited high sensitivity (168.15 and 872.08 μAmM⁻¹cm⁻², respectively) and low detection limits (0.191 and 0.167 μM, respectively). The Na⁺ and K⁺ sensors demonstrated sensitivities of 65.26 and 62.19 mVdec⁻¹, respectively, in a concentration range of 0.01–100 mM. Temperature sensors showed an average rate of resistance change per °C of 0.25%/°C, within a temperature range of 20–40 °C, providing accurate body temperature monitoring. Full article

Wearable tear-based biosensors have garnered substantial interest for real time monitoring with an emphasis on personalized health care. These biosensors utilize major tear biomarkers such as proteins, lipids, metabolites, and electrolytes for the detection and recording of stable biological signals in a non-invasive manner. The present comprehensive review delves deep into the tear composition along with potential biomarkers that can identify, monitor, and predict certain ocular diseases such as dry eye disease, conjunctivitis, eye-related infections, as well as diabetes mellitus. Recent technologies in tear-based wearable point-of-care medical devices, specifically the state-of-the-art and prospects of glucose, pH, lactate, protein, lipid, and electrolyte sensing from tear are discussed. Finally, the review addresses the existing challenges associated with the widespread application of tear-based sensors, which will pave the way for advanced scientific research and development of such non-invasive health monitoring devices. Full article